# Axsome Therapeutics

**Canonical:** https://apis.io/providers/axsome-therapeutics/  
**Website:** https://www.axsome.com/  
**APIs profiled:** 0

Axsome Therapeutics (NASDAQ: AXSM) is a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders. Headquartered at One World Trade Center, New York, Axsome markets three FDA-approved products — Auvelity (dextromethorphan-bupropion) for major depressive disorder, Sunosi (solriamfetol) for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea, and Symbravo (meloxicam-rizatriptan) for the acute treatment of migraine — and is advancing a pipeline including AXS-05 for Alzheimer's disease agitation and smoking cessation, AXS-12 (reboxetine) for narcolepsy, and AXS-14 (esreboxetine) for fibromyalgia. Axsome operates a corporate website and product / HCP microsites but does not expose a public developer API surface; this profile catalogs corporate, product, regulatory, and investor touchpoints rather than programmatic interfaces.

## Kin Score — 15.7 / 100 (emerging)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 15.7).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 15.5 |
| Governance | 15.2 |
| Contract Governance | 15.2 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 23.8 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Axsome Therapeutics Domain Security** — TLSv1.3 · HSTS · DMARC

## Use cases (5)

- **Healthcare Professional Prescribing** — HCP microsites for each marketed product provide prescribing information, dosing, safety, and access support.
- **Patient Access and Adherence** — Patient-facing brand sites with medication guides, copay assistance, and condition education.
- **Investor Relations** — Public disclosures, regulatory filings, and press releases for shareholders, analysts, and financial-data consumers.
- **Scientific Communication** — Publications, congress presentations, and medical-affairs touchpoints for the clinical and scientific community.
- **Clinical Trial Engagement** — Expanded Access Policy and trial-related communications for investigators and patients seeking access to investigational therapies.

## Tags

biopharmaceuticals, Biotechnology, Pharmaceuticals, Healthcare, Life Sciences, Neuroscience, Central Nervous System, Depression, Migraine, Narcolepsy, Alzheimers Disease Agitation, Fibromyalgia, Smoking Cessation, Clinical Pipeline, FDA Approved

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/axsome-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.